New Journey Health Technology Group Co.,LTD (SHE:002219)
China flag China · Delayed Price · Currency is CNY
2.120
+0.020 (0.95%)
Sep 16, 2026, 3:04 PM CST

SHE:002219 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,8653,0503,7893,9033,1533,007
Other Revenue
4.192.619.7811.198.138.79
2,8693,0533,7993,9143,1613,016
Revenue Growth
-15.36%-19.64%-2.94%23.83%4.80%7.49%
Cost of Revenue
2,0312,1772,6232,7422,1692,209
Gross Profit
837.72875.471,1761,173992.42807.44
Selling, General & Admin
521.76576.17805.16874.74690.55717.15
Research & Development
15.0313.359.8627.710.240.44
Other Operating Expenses
26.620.2422.4421.1717.9220.38
Operating Expenses
629.58670.7869.21995.87762.51843
Operating Income
208.14204.78307.21176.87229.91-35.56
Interest Expense
-120.13-123.43-135.03-128.48-142.62-230.03
Interest & Investment Income
54.5113.7928.9759.6426.63
Currency Exchange Gain (Loss)
----0-
Other Non Operating Income (Expenses)
3-3.47-39.84-68.3940.43-17.08
EBT Excluding Unusual Items
96.0182.39146.138.97187.36-256.03
Impairment of Goodwill
------102.59
Gain (Loss) on Sale of Investments
-3.35-3.410.01---
Gain (Loss) on Sale of Assets
3.20.23-0.07-0.19-0.17-0.67
Asset Writedown
-1.22-1.25-1.19-3.38-1.67-17.12
Legal Settlements
-----0.39-0.3
Other Unusual Items
-2.080.019.365.692.4714.33
Pretax Income
92.5677.96154.2311.09187.59-362.39
Income Tax Expense
57.3444.4833.9-28.7722.714.91
Earnings From Continuing Operations
35.2233.48120.3339.86164.89-367.3
Minority Interest in Earnings
-4.69-2.54-5.56-10.89-8.77-4.13
Net Income
30.5430.94114.7728.97156.12-371.43
Net Income to Common
30.5430.94114.7728.97156.12-371.43
Net Income Growth
-50.04%-73.04%296.13%-81.44%--
Shares Outstanding (Basic)
3,2783,2923,2883,2553,2661,866
Shares Outstanding (Diluted)
3,2783,2923,2883,2553,2661,866
Shares Change
4.24%0.10%1.02%-0.33%75.08%-0.02%
EPS (Basic)
0.010.010.030.010.05-0.20
EPS (Diluted)
0.010.010.030.010.05-0.20
EPS Growth
-52.07%-73.07%292.13%-81.38%--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
26.6136.78131.06111.2546.4778.56
Free Cash Flow Per Share
0.010.010.040.030.010.04
Gross Margin
29.20%28.68%30.97%29.96%31.40%26.77%
Operating Margin
7.26%6.71%8.09%4.52%7.27%-1.18%
Profit Margin
1.06%1.01%3.02%0.74%4.94%-12.31%
Free Cash Flow Margin
0.93%1.21%3.45%2.84%1.47%2.60%
EBITDA
348.26357.03480.52384.69385.85127.28
EBITDA Margin
12.14%11.70%12.65%9.83%12.21%4.22%
D&A For EBITDA
140.12152.25173.31207.82155.94162.84
EBIT
208.14204.78307.21176.87229.91-35.56
EBIT Margin
7.26%6.71%8.09%4.52%7.27%-1.18%
Effective Tax Rate
61.94%57.06%21.98%-12.10%-
Revenue as Reported
2,8693,0533,7993,9143,1613,016
Advertising Expenses
-185.26265.25187.8671.9258.15